Clinical Trials Browser

Phase 4 × OTHER × Gemtuzumab × Clear all

NCT01041040 2013-07-31

LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)

Phase 4 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute